TipRanks
Go Ultimate55% OFF

Andrews Robbins Insider Profile

11 Followers

Andrews Robbins, President & CEO, Director at Cogent Biosciences, holds 657.50K shares in Cogent Biosciences (Ticker: COGT), holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP), holds 0.00 shares in Array Biopharma (Ticker: ~ARRY).

Andrews Robbins's Trading History

COGT
Cogent Biosciences
May 21, 2026President & CEO, DirectorUninformative Sell―$20.40M
HARP
Harpoon Therapeutics
Mar 11, 2024―Uninformative Sell―$0.00
~ARRY
Array Biopharma
Jul 30, 2019―Uninformative Sell3.41M$0.00
ARRY
Array Technologies
Apr 03, 2019COOUninformative Buy271.29K$240.76K

You May Also Like

Andrews Robbins insider profile FAQ

What stocks does Andrews Robbins hold?
Andrews Robbins holds: COGT, ~ARRY, HARP, ARRY stocks.
What was Andrews Robbins's most profitable transaction?
Andrews Robbins’s most profitable transaction was an Informative Sell of ~ARRY stock on March 4, 2015. The return on the trade was 63.80%.
What is Andrews Robbins's role in Cogent Biosciences?
Andrews Robbins's role in Cogent Biosciences is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.